|
Treatment
News
These
treatment guidelines are taken from the Center for
Disease Control and Prevention
Morbidity and Mortality Weekly Report
For more MMWR documents, see the Archives
For
additional information regarding the latest treatment
guidelines, visit the US Department of Health and
Human Services' AIDSinfo web site at http://www.aidsinfo.nih.gov/
Morbidity
and Mortality Weekly Report: Sexually Transmitted
Diseases Treatment Guidelines 2002 (PDF File)
|
|
| March
23 , 2004
Safety
and Toxicity of Individual Antiretroviral
Agents in Pregnancy
NUCLEOSIDE & NUCLEOTIDE ANALOGUE REVERSE
TRANSCRIPTASE INHIBITORS
Guidelines
for the Use of Antiretroviral Agents in HIV-1-Infected
Adults and Adolescents
Considerations
for Antiretroviral Therapy in Women
Hydroxyurea
|
| January
20 , 2004
Guidelines
for the Use of Antiretroviral Agents in Pediatric
HIV Infection
PEDIATRIC
ANTIRETROVIRAL DRUG INFORMATION
|
|
November
26, 2003
Recommendations
for Use of Antiretroviral Drugs in Pregnant
HIV-1-Infected Women for Maternal Health and
Interventions to Reduce Perinatal HIV-1 Transmission
in the United States
Safety
and Toxicity of Individual Antiretroviral
Agents in Pregnancy
|
| Adult
and Adolescent Guidelines -November 10, 2003
 Guidelines
for the Use of Antiretroviral Agents in HIV-Infected
Adults and Adolescents
|
| July
18 , 2003
Incorporating
HIV Prevention into the Medical Care of Persons
Living with HIV
|
| Adult
and Adolescent Guidelines - February 4, 2002
Guidelines
for the Use of Antiretroviral Agents in HIV-Infectes
Adults and Adolescents
Supplemental
Documents:
• Considerations
for Antiretroviral Therapy in Women, February
4, 2002
• Hydroxyurea,
February 4, 2002
• Safety
and Toxicity on Individual Retroviral Agents
in Pregnancy, February 4, 2002 |
| Pediatric
Guidelines - December 14, 2001
Guidelines
for the Use of Antiretroviral Agents in Pediatric
HIV Infection
Supplemental
Documents:
• Pediatric
Antiretroviral Drug Information
|
| Perinatal
Guidelines - February 4, 2002
Public
Health Service Task Force Guidelines Recommendations
for the Use of Antiretroviral Drugs in
Pregnant
HIV-1 Infected Women for Maternal Health and
Interventions to Reduce Perinatal HIV-1
Transmission
in the United States
Supplemental
Document:
• Safety
and Toxicity of Individual Antiretroviral
Agents in Pregnancy - updated February 4,
2002
|
| Health-Care
Worker Exposure Guidelines - June 29, 2001
Updated
U.S. Public Health Service Guidelines for
the Management of Occupational Exposures to
HBV, HCV, and HIV and Recommendations for
Postexposure Prophylaxis
Supplemental
Documents (links to documents on CDC website)
• APPENDIX
A. Practice Recommendations for Health-Care
Facilities Implementing the U.S. Public
Health
Service Guidelines for Mangement of Occupational
Exposure to Bloodborne Pathogens
• APPENDIX
B. Management of Occupational Blood Exposures
• APPENDIX
C. Basic and Expanded HIV Postexposure Prophylaxis
Regimens
|
| Nonoccupational
Exposure Considerations -September 25, 1998
Management
of Possible Sexual, Injecting-Drug-Use, or
other Nonoccupational Exposure to HIV, Including
Considerations
Based on Antiretroviral Therapy
|
| Opportunistic
Infection Guidelines - November 28, 2001
2001
USPHS/IDSA Guidelines for the Prevention of
Opportunistic Infections in Persons Infected
with HIV
|
| Tuberculosis
Guidelines (links to documents on CDC website)
Updated
Guidelines for the Use of Rifabutin or Rifampin
for the Treatment and Prevention of Tuberculosis
Among
HIV-Infected Patients Taking Protease Inhibitors
or Nonnucleoside Reverse Transcriptease
Inhibitors,
March 10, 2000
Prevention
and Treatment of Tuberculosis Among Patients
Infected With Human Immunodeficiency Virus,
October
30, 1998 |
From
The U.S. Centers for Disease Control and Prevention:
•
HIV
Partner Counseling and Referral Service: Guidance
•
Revised
Recommendations for HIV Screening of Pregnant Women
•
Revised
Guidelines fo HIV Counseling, Testing, and Referral
|
